SIStemA |
hESC | Human Embryonic Stem Cells |
hiPSC | Human Induced Pluripotent Stem Cells |
LGE | Lateral Ganglionic Eminence |
MGE | Medial Ganglionic Eminence |
MSC | Mesenchymal Stem Cells |
NSC | Neural Stem Cells |
RPE | Retinal Pigment Epithelium |
ATRA | Hutchinson-Gilford syndrome | ORPHA:740 |
DM1 | Myotonic Dystrophy type I | ORPHA:273 |
DMD | Duchenne Muscular Dystrophy | ORPHA:98896 |
EB | Epidermolysis bullosa | ORPHA:304 |
HD | Huntington disease | ORPHA:399 |
LND | Lesch Nyhan Disease | ORPHA:510 |
SMA | Spinal muscular atrophy | ORPHA:83330 |
WFS | Wolfram Syndrome | ORPHA:3463 |
WT | Non affected | |
E3 | CRISPR MBNL1 (-/-) | |
H4 | CRISPR MBNL1 (-/-) MBNL2 (-/-) |
DIV | Day In Vitro: number of day in vitro culture after differentiation and before collection of the sample |
P | Passage: term representing the number of passage before the hESC/hIPSC sample is collected or used for differentiation. Depending on the cell line, a passage corresponds to 5 or 7 days |
KO | Gene Knock-Out, cells with a loss-of-function mutation in a gene. |
KI | Gene Knock-In |
MEF | Mouse Embryonic Fibroblasts |
PO | Poly-L-Ornithine |
LAM | Laminine |
FB | Fibronectine |
GFP | Green Fluorescent protein |